Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 2
1951 2
1952 3
1953 2
1954 1
1956 1
1958 5
1959 1
1960 7
1961 11
1962 25
1963 13
1964 10
1965 24
1966 23
1967 23
1968 30
1969 39
1970 27
1971 40
1972 27
1973 29
1974 24
1975 33
1976 41
1977 60
1978 57
1979 61
1980 76
1981 77
1982 88
1983 101
1984 101
1985 105
1986 112
1987 129
1988 154
1989 136
1990 177
1991 170
1992 177
1993 211
1994 214
1995 216
1996 204
1997 249
1998 227
1999 215
2000 235
2001 224
2002 244
2003 256
2004 268
2005 270
2006 243
2007 284
2008 287
2009 307
2010 350
2011 364
2012 363
2013 354
2014 394
2015 401
2016 429
2017 430
2018 410
2019 417
2020 516
2021 629
2022 310
Text availability
Article attribute
Article type
Publication date

Search Results

10,862 results
Results by year
Filters applied: . Clear all
Page 1
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. Among authors: watanabe y. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine.
Watanabe Y, Mendonça L, Allen ER, Howe A, Lee M, Allen JD, Chawla H, Pulido D, Donnellan F, Davies H, Ulaszewska M, Belij-Rammerstorfer S, Morris S, Krebs AS, Dejnirattisai W, Mongkolsapaya J, Supasa P, Screaton GR, Green CM, Lambe T, Zhang P, Gilbert SC, Crispin M. Watanabe Y, et al. ACS Cent Sci. 2021 Apr 28;7(4):594-602. doi: 10.1021/acscentsci.1c00080. Epub 2021 Apr 2. ACS Cent Sci. 2021. PMID: 34056089 Free PMC article.
Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice.
Nojiri S, Tsuchiya A, Natsui K, Takeuchi S, Watanabe T, Kojima Y, Watanabe Y, Kamimura H, Ogawa M, Motegi S, Iwasawa T, Sato T, Kumagai M, Ishii Y, Kitayama T, Li YT, Ouchi Y, Shimbo T, Takamura M, Tamai K, Terai S. Nojiri S, et al. Among authors: watanabe y. Inflamm Regen. 2021 Sep 27;41(1):28. doi: 10.1186/s41232-021-00177-4. Inflamm Regen. 2021. PMID: 34565478 Free PMC article.
The Role of Neuropeptide Y in the Nucleus Accumbens.
Tanaka M, Yamada S, Watanabe Y. Tanaka M, et al. Among authors: watanabe y. Int J Mol Sci. 2021 Jul 7;22(14):7287. doi: 10.3390/ijms22147287. Int J Mol Sci. 2021. PMID: 34298907 Free PMC article. Review.
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.
Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T. Hata A, et al. Among authors: watanabe y. J Clin Oncol. 2022 Jan 10;40(2):180-188. doi: 10.1200/JCO.21.01315. Epub 2021 Nov 18. J Clin Oncol. 2022. PMID: 34793245 Clinical Trial.
Targeting RB1 Loss in Cancers.
Linn P, Kohno S, Sheng J, Kulathunga N, Yu H, Zhang Z, Voon D, Watanabe Y, Takahashi C. Linn P, et al. Among authors: watanabe y. Cancers (Basel). 2021 Jul 25;13(15):3737. doi: 10.3390/cancers13153737. Cancers (Basel). 2021. PMID: 34359636 Free PMC article. Review.
Five-coordinate iridium(III) complex with ΔΛ chirality.
Takimoto K, Watanabe Y, Yoshida J, Sato H. Takimoto K, et al. Among authors: watanabe y. Dalton Trans. 2021 Oct 5;50(38):13256-13263. doi: 10.1039/d1dt01960k. Dalton Trans. 2021. PMID: 34608912
10,862 results
You have reached the last available page of results. Please see the User Guide for more information.